Yıl: 2015 Cilt: 43 Sayı: 4 Sayfa Aralığı: 269 - 273 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Vitamin D ve Anestezi

Öz:
Vitamin D; vücutta sadece kalsiyum, fosfor metabolizmasını de- ğil aynı zamanda birçok organ sistemini etkileyen bir vitamindir ve son yıllarda özellikle immün sistem üzerine etkilerinden dolayı daha çok dikkat çekmeye başlamıştır. Vitamin D eksikliği ise hala yaygın olarak toplumda gözlenebilen bir klinik durumdur. Dolayı- sıyla da anestezi uygulamalarında sıklıkla vitamin D eksikliği olan hasta ile karşılaşılabilmektedir. Eksikliğinde yoğun bakımda kalış sürelerinin uzaması, mortalite ve morbiditenin artışının yanı sıra kronik hastalıklarla sıklıkla birlikte olabilmesi vitamin D eksikli- ğinin önemini bir kat daha artırmaktadır. Yapılan çalışmalardan elde edilen sonuçlar vitamin D eksikliğinin kötü cerrahi prognozla ilgisinin olup olmadığının sorgulanmasına neden olmuştur. Biz de vitamin D eksikliğini ve buna bağlı ortaya çıkabilecek olumsuz sonuçları anestezistler açısından değerlendirdik.
Anahtar Kelime:

Konular: Anestezi

Vitamin D and Anaesthesia

Öz:
Vitamin D is a vitamin not only associated with calcium-phosphorus metabolism but also affects many organ systems. Because of its effect on the immune system in recent years, it has attracted much attention. Vitamin D deficiency is a clinical condition that can be widely observed in the society. Thus, patients with vitamin D deficiency are often seen in anaesthesia practice. In the absence of vitamin D, prolongation of intensive care unit stay, increase in mortality and morbidity and also association of chronic diseases further increase the importance of vitamin D deficiency. The results obtained from studies have led to the question of whether poor surgical outcome is associated with vitamin D deficiency. We assessed the vitamin D deficiency and its negative consequences for the anaesthesiologist.
Anahtar Kelime:

Konular: Anestezi
Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Wranicz J, Szostak-Węgierek D. Health outcomes of vıtamın d.part 1. characterıstıcs and classıc role. Rocz Panstw Zakl Hig 2014; 65: 179-84.
  • 2. Holick M. Vitamin D: Sources and health benefits. Standardy Medyczne. Pediatria 2012; 9: 705-15.
  • 3. Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holick MF. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008; 52: 1949-56. [CrossRef]
  • 4. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-81. [CrossRef]
  • 5. Forrest KYZ, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011; 31: 48-54. [CrossRef]
  • 6. Uçar F, Taşlıpınar MY, Soydaş AÖ, Özcan N. Ankara Etlik İhtisas Eğitim ve Araştırma Hastanesine Başvuran Hastalarda 25- OH Vitamin D Düzeyleri. Eur J Basic Med Sci 2012; 2: 12-5.
  • 7. Skarphedinsdottir SJ, Sigurdsson MI, Coursin DB, Head D, Springman SR, Wang S, et al. Vitamin D deficiency in anesthesia department caregivers at the end of winter. Acta Anaesthesiol Scand 2014; 58: 802-6. [CrossRef]
  • 8. Lavie CJ, Lee JH, Milani RV. Vitamin D and cardiovascular disease: Will it live upto its hype? J Am Coll Cardiol 2011; 58: 1547-56. [CrossRef]
  • 9. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006; 84: 18-28.
  • 10. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin Endocrinol Metab 2008; 93: 677-81. [CrossRef]
  • 11. Lee P. Vitamin D metabolism and deficiency in critical illness. Best Pract Res Clin Endocrinol Metab 2011; 25: 769-81. [CrossRef]
  • 12. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005; 26: 662-87. [CrossRef]
  • 13. Harvey RA, Champe PC, Biyokimya Lippincott’s Illustrated Reviews (Çev. Edt. Ulukaya E.) 5. Ünite Metabolizmasının düzenlenmesi, 28. Bölüm Vitaminler (Çev: Delen Akçay Y), 3.baskı, İstanbul: Nobel Tıp Yayınevi; 2007: 384-7.
  • 14. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-72. [CrossRef]
  • 15. Bakhtiyarova S, Lesnyak O, Kyznesova N, Blankenstein MA, Lips P. Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int 2006; 17: 441-6. [CrossRef]
  • 16. Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based3-year interventionstudy. J Bone Miner Res 2004; 19: 370-8. [CrossRef]
  • 17. Ozgocmen S, Bulut S, Ilhan N, Gulkesen A, Ardicoglu O, Ozkan Y. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab 2005; 23: 309-13. [CrossRef]
  • 18. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008; 14: 1220-4. [CrossRef]
  • 19. Correale J, Ysrraelit MC, Gaitán MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009; 132: 1146- 60. [CrossRef]
  • 20. Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005; 11: 266-71. [CrossRef]
  • 21. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol 2010; 9: 599-61. [CrossRef]
  • 22. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006; 92: 39-48. [CrossRef]
  • 23. Lee JH, O’Keefe JH, Bell D, Hensrud DD, Holic MF. Vitamin D deficiency an important, common and easily treatable cardiovascular riskfactor? J Am Coll Cardiol 2008; 52: 1949-56. [CrossRef]
  • 24. Lin J, Manson JE, Lee IM, Cook NR, Buring JE, Zhang SM. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007; 167: 1050-9. [CrossRef]
  • 25. Herr C, Greulich T, Koczulla RA, Meyer S, Zakharina T, Branscheidt M, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011; 12: 31. [CrossRef]
  • 26. Vacek JL, Vanga SR, Good M, Lai SM, Lakkireddy D, Howard PA. Vitamin D deficiency and supplementation and relation to cardiovascular health. Am J Cardiol 2012; 109: 359-63. [CrossRef]
  • 27. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomizedtrial. Am J Clin Nutr 2007; 85: 1586-91.
  • 28. Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H. Vitamin D supplementation forthe prevention of acute respiratory tractinfection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 2010; 202: 809-14. [CrossRef]
  • 29. Autier P, Gandini S. Vitamin D supplementation and total mortality: a metaanalysis of randomized controlled trials. Arch Intern Med 2007; 167: 1730-7. [CrossRef]
  • 30. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol 2010; 299: 1226-34. [CrossRef]
  • 31. Kassi E, Adamopoulos C, Basdra EK, Papavassiliou AG. Role of vitamin D in atherosclerosis. Circulation 2013; 128: 2517-31. [CrossRef]
  • 32. Turan A, Grady M, You J, Mascha EJ, Keeyapaj W, Komatsu R, et al. Low vitamin D concentration is not associated with increased mortality and morbidity after cardiac surgery. PLoS One 2013; 8: e63831. [CrossRef]
  • 33. Krishnan A, Ochola J, Mundy J, Jones M, Kruger P, Duncan E, et al. Acute fluid shifts influence the assessment of serum vitamin D status in critically ill patients. Critical Care 2010; 14: 216-23 [CrossRef].
  • 34. Badawi A, Sayegh S, Sadoun E, Al-Thani M, Arora P, Haddad PS. Relationship between insulin resistance and plasma vitamin D in adults. Diabetes Metab Syndr Obes 2014; 7: 297-303. [CrossRef]
  • 35. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001; 358: 1500-3. [CrossRef]
  • 36. Deleskog A, Hilding A, Brismar K, Hamsten A, Efendic S, Östenson CG. Low serum 25-hydroxyvitamin D level predicts progression to type 2 diabetes in individuals with prediabetes but not with normal glucose tolerance. Diabetologia 2012; 55: 1668-78. [CrossRef]
  • 37. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-5.
  • 38. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-13. [CrossRef]
  • 39. Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-10. [CrossRef]
  • 40. Schomig M, Ritz E. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites. Nephrol Dial Transplant 2000; 15(Suppl 5): 18-24. [CrossRef]
  • 41. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-80. [CrossRef]
  • 42. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D(3) users in a haemodialysis population. Nephrol Dial Transplant 2004; 19: 179-84. [CrossRef]
  • 43. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, et al. Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 2005; 16: 1115-25. [CrossRef]
  • 44. Science M, Maguire JL, Russell ML, Smieja M, Walter SD, Loeb M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin Infect Dis 2013; 57: 392-7. [CrossRef]
  • 45. Berry DJ, Hesketh K, Power C, Hypponen E. Vitamin D status has a linear association with seasonal infections and lung function in British adults. Br J Nutr 2011; 106: 1433-40. [CrossRef]
  • 46. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One 2010; 5: e11088. [CrossRef]
  • 47. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169: 384-90. [CrossRef]
  • 48. Korn S, Hübner M, Jung M, Blettner M, Buhl R. Severe and uncontrolled adult asthma is associated with vitamin D insufficiency and deficiency. Respir Res 2013; 14: 25. [CrossRef]
  • 49. Goleva E, Searing DA, Jackson LP, Richers BN, Leung DY. Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J Allergy Clin Immunol 2012; 129: 1243-51. [CrossRef]
  • 50. Erkkola M, Kaila M, Nwaru BI, Kronberg-Kippila C, Nevalainin J, Veijola R. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-yearold children. Clin Exp Allergy 2009; 39: 875-82. [CrossRef]
  • 51. Bener A, Ehlayel MS, Tulic MK, Hamid Q. Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol 2012; 157: 168-75. [CrossRef]
  • 52. Camargo CA Jr, Ingham T, Wickens K, Thadhani R, Silvers KM, Epton MJ, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 2011; 127: e180-7. [CrossRef]
  • 53. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-3.
  • 54. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S. Evidence for alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 1985; 76: 370-3. [CrossRef]
  • 55. Hyldstrup L, Andersen T, McNair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol 1993; 129: 393-8. [CrossRef]
  • 56. Bell NH, Epstein S, Shary J, Greene V, Oexmann MJ, Shaw S. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism. J Bone Miner Res 1988; 3: 489-95. [CrossRef]
  • 57. Holick MF, Matsuoka LY, Wortsman J. Age, vitamin D, and solar ultraviolet. Lancet 1989; 2: 1104-5. [CrossRef]
  • 58. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1,25-dihydroxyvitaminD3 inhibits angiogenesis in vitro and in vivo. Circ Res 2000; 87: 214-20. [CrossRef]
  • 59. Mathieu C, Adorini L. Thecoming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 2002; 8: 174-9. [CrossRef]
  • 60. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 2004; 80: 1717-20.
  • 61. Lange U, Jung O, Teichmann J, Neeck G. Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int 2001; 12: 1031-5. [CrossRef]
  • 62. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003; 134: 128-32. [CrossRef]
  • 63. Balden R, Selvamani A, Sohrabji F. Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats. Endocrinology 2012; 153: 2420-35. [CrossRef]
  • 64. McGrath J, Selten JP, Chant D. Longterm trends in sunshine duration and its association with schizophrenia birth rates and age at first registration-data from Australia and the Netherlands. Schizophr Res 2002; 54: 199-212. [CrossRef]
  • 65. Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc 2003; 78: 1463-70. [CrossRef]
  • 66. Quraishi SA, Bittner EA, Blum L, McCarthy CM, Bhan I, Camargo CA Jr. Prospective study of vitamin D status at initiation of care in critically ill surgical patients and risk of 90-day mortality. Crit Care Med 2014; 42: 1365-71. [CrossRef]
  • 67. Rech MA, Hunsaker T, Rodriquez J. Deficiency in 25-hydroxyvitamin D and 30-day mortality in patients with severe sepsis and septic shock. Am J Crit Care 2014; 23: 72-9. [CrossRef]
  • 68. Turan A, Hesler BD, You J, Saager L, Grady M, Komatsu R, et al. The association of serum vitamin D concentration with serious complications after noncardiac surgery. Anesth Analg 2014; 119: 603-12. [CrossRef]
  • 69. Joshi A, Bhadade R, Varthakavi PK, DeSouza R, Bhagwat NM, Chadha MD. Vitamin D deficiency is associated with increased mortality in critically ill patients especially in those requiring ventilatory support. Indian J Endocrinol Metab 2014; 18: 511-5. [CrossRef]
APA BİRİCİK E, güneş y (2015). Vitamin D ve Anestezi. , 269 - 273.
Chicago BİRİCİK Ebru,güneş yasemin Vitamin D ve Anestezi. (2015): 269 - 273.
MLA BİRİCİK Ebru,güneş yasemin Vitamin D ve Anestezi. , 2015, ss.269 - 273.
AMA BİRİCİK E,güneş y Vitamin D ve Anestezi. . 2015; 269 - 273.
Vancouver BİRİCİK E,güneş y Vitamin D ve Anestezi. . 2015; 269 - 273.
IEEE BİRİCİK E,güneş y "Vitamin D ve Anestezi." , ss.269 - 273, 2015.
ISNAD BİRİCİK, Ebru - güneş, yasemin. "Vitamin D ve Anestezi". (2015), 269-273.
APA BİRİCİK E, güneş y (2015). Vitamin D ve Anestezi. Turkish Journal of Anaesthesiology and Reanimation, 43(4), 269 - 273.
Chicago BİRİCİK Ebru,güneş yasemin Vitamin D ve Anestezi. Turkish Journal of Anaesthesiology and Reanimation 43, no.4 (2015): 269 - 273.
MLA BİRİCİK Ebru,güneş yasemin Vitamin D ve Anestezi. Turkish Journal of Anaesthesiology and Reanimation, vol.43, no.4, 2015, ss.269 - 273.
AMA BİRİCİK E,güneş y Vitamin D ve Anestezi. Turkish Journal of Anaesthesiology and Reanimation. 2015; 43(4): 269 - 273.
Vancouver BİRİCİK E,güneş y Vitamin D ve Anestezi. Turkish Journal of Anaesthesiology and Reanimation. 2015; 43(4): 269 - 273.
IEEE BİRİCİK E,güneş y "Vitamin D ve Anestezi." Turkish Journal of Anaesthesiology and Reanimation, 43, ss.269 - 273, 2015.
ISNAD BİRİCİK, Ebru - güneş, yasemin. "Vitamin D ve Anestezi". Turkish Journal of Anaesthesiology and Reanimation 43/4 (2015), 269-273.